SKLB-197
|
化合物 SKLB-197
|
2713577-16-1
|
CHD1Li6.11
|
化合物 CHD1LI 6.11
|
2716890-91-2
|
Calicheamicin
|
卡利奇霉素
|
108212-75-5
|
Selonsertib
|
|
1448428-04-3
|
GSK481
|
CS-2186
|
1622849-58-4
|
SZL P1-41
|
|
222716-34-9
|
GSK872
|
|
1346546-69-7
|
AD80
|
|
1384071-99-1
|
DBCO-C3-Acid
|
DBCO-ACID
|
1207355-31-4
|
BTSA1
|
CS-2853
|
314761-14-3
|
(2-bromo-3-nitrophenyl)methanol
|
(2-溴-3-硝基苯基)甲醇
|
90407-20-8
|
Micafungin Impurity K
|
米卡芬净钠有关物质2
|
1392514-03-2
|
S-Hydroprene
|
烯虫乙酯
|
65733-18-8
|
(S)-2-((R)-3-(4-chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide
|
化合物T9281
|
1404117-65-2
|
2-hydroxy-1,3,2-oxazaphosphinane 2-oxide
|
环磷酰胺杂质16
|
45633-04-3
|
Sodium Picosulfate Impurity 31
|
匹可硫酸杂质34
|
105745-58-2
|
Teneligliptin Impurity 7
|
替格列汀杂质
|
1415908-67-6
|
Amiselimod hydrochloride
|
MT-1303盐酸盐
|
942398-84-7
|
ML380
|
|
1627138-52-6
|
QX77
|
|
1798331-92-6
|
(R)-2,4-dihydroxy-3,3-dimethyl-N-(3-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-3-oxopropyl)butanamide
|
|
1224691-12-6
|
ASP4132
|
(6-(1-((6-甲氧基吡啶-3-基)甲基)哌啶-4-基)-1H-苯并[D]咪唑-2-基)(4-(4-(三氟甲基)苄基)哌嗪-1-基)甲酮 双对甲苯磺酸盐
|
1640294-30-9
|
Silybin
|
水飞蓟宾
|
802918-57-6
|
Sobetirome
|
|
211110-63-3
|
STF-083010
|
STF 083010
|
307543-71-1
|
Pexidartinib
|
培西达替尼
|
1029044-16-3
|
Tarloxotinib bromide
|
1636180-98-7
|
1636180-98-7
|
Lipoic Acid Impurity 75
|
硫辛酸杂质25
|
108841-56-1
|
Sitagliptin Impurity 90
|
西他列汀杂质174
|
2892260-32-9
|
Hirudin (54-65) (desulfated)
|
水蛭素
|
113274-56-9
|
N-((1R,3s,5S)-8-benzyl-8-azabicyclo[3.2.1]octan-3-yl)isobutyramide
|
N-(8-苄基-8-氮杂双环[3.2.1]辛-3-基-外向)-2-甲基丙酰胺
|
376348-67-3
|
Imatinib Impurity 72
|
伊马替尼元甲基哌嗪杂质
|
1246819-59-9
|
PF-04418948
|
PF04418948
|
1078166-57-0
|
CB1-IN-1
|
1-(2,4-二氯苯基)-N-1-哌啶基-4-[[(1-吡咯烷基磺酰基)氨基]甲基]-5-[5-[2-[4-(三氟甲基)苯基]乙炔基]-2-噻吩基]-1H-吡唑-3-甲酰胺
|
1429239-98-4
|
Nazartinib
|
EGF816
|
1508250-71-2
|
PF-06409577
|
|
1467057-23-3
|
Mavacoxib
|
吗伐考昔
|
170569-88-7
|
IKK epsilon-IN-1
|
CS-1801
|
1292310-49-6
|
Elafibranor
|
GFT505
|
923978-27-2
|
MK-1064
|
|
1207253-08-4
|
ASK1-IN-1
|
|
1262041-49-5
|
IDO-IN-2
|
|
1668565-74-9
|
Inavolisib
|
GDC-0077
|
2060571-02-8
|
PF-04745637
|
1-(4-chlorophenyl)-N-(2-(4-hydroxy-4-(trifluoromethyl)piperidin-1-yl)-3-phenylpropyl)cyclopentanecarboxamide
|
1917294-46-2
|
Izilendustat
|
1303512-02-8
|
1303512-02-8
|
5'-(3-formyl-4-hydroxyphenyl)-4,4''-dihydroxy-[1,1':3',1''-terphenyl]-3,3''-dicarbaldehyde
|
1,3,5-TRIS(3'-醛基-4‘-羟基苯)苯
|
1222784-84-0
|
Arotinolol
|
阿罗洛尔
|
68377-92-4
|
Benazepril-d5 HCl
|
贝那普利杂质
|
1279026-26-4
|
2'-Deoxy-2'-fluoroguanosine
|
2'-脱氧-2'-氟鸟苷
|
78842-13-4
|
Celecoxib Impurity 50
|
塞来昔布杂质57
|
94856-20-9
|
(2-bromo-5-nitrophenyl)methanol
|
2-溴-5-硝基苄醇
|
332883-48-4
|
MK-8617
|
|
1187990-87-9
|
PF-8380
|
4-[3-氧代-3-(2-氧代-2,3-二氢苯并恶唑-6-基)丙基]哌嗪-1-羧酸 3,5-二氯苄酯
|
1144035-53-9
|
tert-butyl 3,6-diazabicyclo[3.1.0]hexane-3-carboxylate
|
3-N-BOC-3,6-二氮杂双环[3.1.0]己烷
|
1262407-18-0
|
Cytosporone B
|
CSN-B
|
321661-62-5
|
TM38837
|
化合物TM38837
|
1253641-65-4
|
GSK2982772
|
|
1622848-92-3
|
Iptacopan hydrochloride
|
化合物LNP023 HYDROCHLORIDE
|
1646321-63-2
|
GPR120 Agonist 2
|
3-(4-((5-氯-2,2-二甲基-2,3-二氢苯并呋喃-7-基)甲氧基)-2,3-二甲基苯基)丙酸
|
1234844-11-1
|
Pemigatinib
|
佩米替尼
|
1513857-77-6
|
(2,5-dibromo-3-nitrophenyl)methanol
|
米拉贝隆杂质52
|
2092378-78-2
|
tert-butyl (3-azabicyclo[3.1.0]hexan-1-yl)carbamate
|
1-[(N-叔丁氧羰基)氨甲基]-3-氮杂双环[3.1.0]己烷
|
204991-14-0
|
tert-butyl 1-amino-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
3-氮杂双环[3.1.0]己烷-3-甲酸, 1-氨基-, 1,1-二甲基乙基 酯
|
489438-95-1
|
Ciguatoxin 1
|
Ciguatoxin
|
11050-21-8
|
Besifloxacin hydrochloride
|
盐酸贝西沙星
|
405165-61-9
|
6-Desfluoro-6-hydroxy Risperidone
|
6-去氟-6-羟基利培酮
|
106266-11-9
|
BAM7
|
|
331244-89-4
|
AZD7594
|
AZD-7594
|
1196509-60-0
|
pentyl 2-(3,5-dihydroxy-2-nonanoylphenyl)acetate
|
化合物 Amoitone B
|
1257228-26-4
|
JMS-17-2
|
Pyrrolo[1,2-a]quinoxalin-4(5H)-one,5-[3-[4-(4-chlorophenyl)-1-piperidinyl]propyl]-
|
1380392-05-1
|
Ciguatoxin 3
|
|
139341-09-6
|
Mosapride Impurity V
|
Mosapride Impurity J
|
112886-56-3
|
EP4 receptor antagonist 1
|
|
2287259-07-6
|
4-amino-5-bromo-2-methoxybenzoic acid
|
4-氨基-5-溴-2-甲氧基苯甲酸
|
35290-97-2
|
Mesalazine Impurity 33
|
美沙拉嗪杂质22
|
143228-42-6
|
Pendimethalin
|
二甲戊灵
|
40487-42-1
|
Lasmiditan
|
拉米地坦
|
439239-90-4
|
(2R,3R)-2,3-dihydroxy-4-methoxy-4-oxobutanoic acid
|
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester
|
3333-46-8
|
Voxelotor
|
沃塞洛托
|
1446321-46-5
|
Desdifluoro Dolutegravir
|
Dolutegravir Impurity 7
|
2244161-71-3
|
17-hydroxy-3,6,9,12,15-pentaoxaheptadecyl 2-hydroxy-2,2-di(thiophen-2-yl)acetate
|
WMDWSORRVDMCMX-UHFFFAOYSA-N
|
1797030-08-0
|
Clofarabine Impurity 15
|
克罗拉滨杂质11
|
1140251-36-0
|
4-(bromomethyl)-5-methyl-1,3-dioxol-2-one
|
4-溴甲基-5-甲基-1,3-间二氧杂环戊烯-2-酮
|
80715-22-6
|
4'-chloro-[1,1'-biphenyl]-3,5-diol
|
4'-氯-[1,1'-联苯]-3,5-二醇
|
203645-99-2
|
Lercanidipine Impurity 36
|
2-[(3-硝基苯基)亚甲基]-3-氧代丁酸乙酯
|
39562-16-8
|
RMC-4550
|
|
2172651-73-7
|
TBK1/IKKepsilon-IN-5
|
Benzonitrile, 5-[4-[[4-[4-(3-oxetanyl)-1-piperazinyl]phenyl]amino]-1,3,5-triazin-2-yl]-2-[(tetrahydro-2H-pyran-4-yl)oxy]-
|
1893397-65-3
|
2'-Fluoro-2'-deoxycytidine
|
2'-脱氧-2-氟胞苷
|
10212-20-1
|
Dolutegravir Impurity 53
|
多替拉韦杂质
|
2244161-72-4
|
Ketorolac Impurity 44
|
酮咯酸杂质34
|
66635-89-0
|
2'-Fluoro-2'-deoxyadenosine
|
2'-氟-2'-脱氧腺苷
|
64183-27-3
|
2,2-dichloro-N-(o-tolyl)acetamide
|
2,2-DICHLORO-N-O-TOLYL-ACETAMIDE
|
14985-83-2
|
Milciclib
|
PHA-848125
|
802539-81-7
|
(4-bromo-3-nitrophenyl)methanol
|
(4-溴-3-硝基苯基)甲醇
|
145547-97-3
|
GLPG1690
|
GLPG-1690
|
1628260-79-6
|
Niraparib Impurity 1
|
尼拉帕尼代谢物 M1
|
1476777-06-6
|
ML385
|
|
846557-71-9
|
5-(tert-butyl)-2-fluoro-4-((4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methoxy)benzonitrile
|
5-(叔丁基)-2-氟-4-((4-甲基-5-氧代-4,5-二氢-1H-1,2,4-三唑-3-基)甲氧基)苯甲腈
|
2088365-27-7
|
D-glucurono-6,3-lactone
|
葡醛内酯
|
32449-92-6
|
H-beta-Ala-AMC TFA
|
|
201847-54-3
|